Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack D Bui

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Journal of Extracellular Vesicles|September 27, 2024
MAP kinase kinase 1 (MEK1) within extracellular vesicles inhibits tumour growth by promoting anti-tumour immunityStephen C Searles, Wei-Shan Chen, Jarrod D Yee, et al.
International Immunology|January 9, 2015
Drak2 is not required for tumor surveillance and suppressionBenjamin A Edwards, Tarsha L Harris, Helen Floersh, et al.
Cancer Immunology Research|August 4, 2016
Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 ResistanceAndrew L Doedens, Mark P Rubinstein, Emilie T Gross, et al.
European Journal of Immunology|June 29, 2012
A dual function of NKG2D ligands in NK-cell activationElizabeth E Cheney, Erica L Wise, Jack D Bui, et al.
Immunity|November 24, 2019
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 PathwaysYunlong Zhao, Calvin K Lee, Chia-Hao Lin, et al.
Anesthesia and Analgesia|March 24, 2018
Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief ReportAngela Meier, Emilie T E Gross, Jan M Schilling, et al.
Nature Biomedical Engineering|December 21, 2021
Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissueHuawei Wang, Christina N Alarcón, Bei Liu, et al.
Nature Communications|April 1, 2021
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumorsBaharak Bahmani, Hua Gong, Brian T Luk, et al.
Cancer Research|November 17, 2011
ERK1/2 regulation of CD44 modulates oral cancer aggressivenessNancy P Judd, Ashley E Winkler, Oihana Murillo-Sauca, et al.
Cell Reports|August 23, 2016
Nrf2 Induces IL-17D to Mediate Tumor and Virus SurveillanceRobert Saddawi-Konefka, Ruth Seelige, Emilie T E Gross, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Extracellular Vesicles|September 27, 2024
MAP kinase kinase 1 (MEK1) within extracellular vesicles inhibits tumour growth by promoting anti-tumour immunityStephen C Searles, Wei-Shan Chen, Jarrod D Yee, et al.
International Immunology|January 9, 2015
Drak2 is not required for tumor surveillance and suppressionBenjamin A Edwards, Tarsha L Harris, Helen Floersh, et al.
Cancer Immunology Research|August 4, 2016
Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 ResistanceAndrew L Doedens, Mark P Rubinstein, Emilie T Gross, et al.
European Journal of Immunology|June 29, 2012
A dual function of NKG2D ligands in NK-cell activationElizabeth E Cheney, Erica L Wise, Jack D Bui, et al.
Immunity|November 24, 2019
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 PathwaysYunlong Zhao, Calvin K Lee, Chia-Hao Lin, et al.
Anesthesia and Analgesia|March 24, 2018
Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief ReportAngela Meier, Emilie T E Gross, Jan M Schilling, et al.
Nature Biomedical Engineering|December 21, 2021
Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissueHuawei Wang, Christina N Alarcón, Bei Liu, et al.
Nature Communications|April 1, 2021
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumorsBaharak Bahmani, Hua Gong, Brian T Luk, et al.
Cancer Research|November 17, 2011
ERK1/2 regulation of CD44 modulates oral cancer aggressivenessNancy P Judd, Ashley E Winkler, Oihana Murillo-Sauca, et al.
Cell Reports|August 23, 2016
Nrf2 Induces IL-17D to Mediate Tumor and Virus SurveillanceRobert Saddawi-Konefka, Ruth Seelige, Emilie T E Gross, et al.
Pageof 8